medicaid glp 1 coverage Who Gets the Shot? GLP-1 Access by State What to Know About the
Description
Extending the findings from the UK cohort study, additional real-world data derived from the Taiwan National Health Insurance Databasewhich encompasses Asian populations characterized by lower gallstone prevalence, low-fat and high-fiber dietary patterns, and lower body mass indexalso documented an elevated risk of biliary-related diseases linked to GLP-1 RAs compared with SGLT-2 inhibitors [36]
These benefits were consistent regardless of baseline diabetes [47] or glycemic status [52]
doi: 10.1073/pnas.89.18.8641
C.TsikisS
GLP-1 drugs strengthen those natural stop signals
Its unclear whether Ozempic & co
